Artificial Intelligence-based Voice Assessment of Children and Adults Respiratory Conditions (AIRWAY-VDAP)

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Not yet enrolling

Conditions: Asthma; Airway Disease; Bronchiolitis; Cancer of Head and Neck; Radiotherapy

Treatments: Device: Wevosys acoustic analysis

Study type: Interventional

Funder types: Other

Identifiers

NCT06630078

ID6812

Details and patient eligibility

About

Acute and Chronic respiratory conditions represent a leading cause of death and morbidity in children and adults worldwide. The diagnosis of bronchiolitis and asthmatic exacerbations is based on clinical, and mostly subjective, clinical parameters with moderately accurate prognostic role. Patients undergoing neck radiotherapy need invasive assessments of larynx. A simple biomarker like Voice may facilitate the management of these conditions. Recent studies showed that VOICE may be used as a good and easy biomarker to diagnose and monitor several respiratory and non-respiratory conditions. A prospective study aimed to collected VOICE and other clinical data in adults and children with common acute and chronic respiratory conditions at high impact on healthcare systems will be performed. VOICE-omic data will be linked with clinical findings generating data integration, using artificial intelligence technology to develop a Decision Support Systems to provide the basis for non-invasive personalised early recognition, diagnosis, monitoring and prognosis of patients with these conditions.

Enrollment: 200 estimated patients

Sex: All

Ages: 12 months to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children with bronchiolitis <24 months of age clinically characterized according to the clinical definition accepted by international literature (Ralstone);
• Children with asthma according to most recent GINA guidance (Global Initiative for Asthma, 2022) aged 6-12 years in a phase of proper control or during acute exacerbations;
• Adults with upper aerodigestive tract chronic or acute clinical conditions;
• Adults with pathologic diagnosis of head and neck cancer addressed to radiotherapy with or without chemotherapy for primary treatment of the tumor.

Exclusion criteria

• Children with comorbidities including genetic disorders;
• Children with other chronic respiratory conditions (bronchodysplasia, cystic fibrosis);
• Children with primary immunologic diseases;
• Children with prematurity;
• Children with other respiratory conditions not part of the inclusion criteria (examples: pneumonia, tonsillitis);
• Adults over 70 years old or with neurological diseases;
• Adults with syndromic disease;
• Adults with malformations of upper aero-digestive tract;
• Adults with history of head and neck surgery or not able to sustain a vocalism for more than 3 sec.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

200 participants in 1 patient group

Case group

Experimental group

Description:

children with bronchiolits, controlled asthma and asthmatic re-exacerbations and adults with primary upper aero-digestive tract affections or secondary to radiotherapy

Treatment:

Device: Wevosys acoustic analysis